Please call 800-633-7377 for a personal consultation between 8:30 a.m. and 5 p.m. Monday through Friday.
You can also call the appointment center to schedule, change or cancel an appointment or ask questions.
The Division of Infectious Diseases concentrates its research efforts on developing laboratory and clinical research programs that focus on characterization of specific clinically important pathogens in regards to antibiotic utilization, epidemiology and infection control, novel diagnostics and therapeutics, and mechanisms of antimicrobial resistance. The laboratory component focuses specifically on invasive fungal infections and highly resistant bacteria. Our emphasis seeks to translate results from these projects into clinical practice to improve patient care and the outcomes of patients with serious infections.
The challenge of infectious diseases presents across the spectrum of medical and surgical specialties. There are a number of collaborative research projects ongoing with other departments and divisions at Beaumont including several of the surgery sub-specialties, quality and safety, and radiation oncology to explore these multi-disciplinary research questions.
In addition, Infectious Diseases conducts and manages numerous sponsored clinical trials in Clostridium difficile diagnosis and treatment as well as new antimicrobial interventions.
Ongoing contributions to research and clinical practice by Beaumont’s Infectious Diseases group are best illustrated by the success of their multidisciplinary approach that combined clinical, molecular, and epidemiological investigation to enable the first identification and analysis in the United States of Vancomycin Intermediate Staphylococcus aureus (VISA), an emerging and highly resistant organism that presents challenges to healthcare.
Christopher Carpenter, M.D.
Section Head, Infectious Diseases, Director Infectious Diseases Fellowship Program
Invasive fungal infections, HIV infection, antimicrobial utilization
Jeffrey Band, M.D.
Director, International Medicine; Corporate Epidemiologist
Carl Lauter, M.D.
Infections in the compromised and immunodeficient host.
Matthew Sims, M.D. Ph.D.
Director, Infectious Diseases Research
Invasive fungal infections, antimicrobial resistance, clinical therapeutic failures, antifungal therapy, emerging pathogenic fungi
John Szela, M.D.
Director, ID Ambulatory Clinic